Methylphenidate Capsule, Extended Release
Product Images NDC 0781-2364

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Methylphenidate (NDC 0781-2364). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of methylphenidate hydrochloride showing the phenyl, methyl ester, and piperidine ring components with an associated hydrochloride molecule.*

FDA Label Image

Fig 1 (Image 02)

A line graph comparing mean dl-methylphenidate plasma levels (ng/mL) over time (hours) after administration of two forms of methylphenidate: 40 mg extended-release capsules once daily and 20 mg tablets twice daily. The graph displays plasma concentration changes up to 24 hours post-dosing, illustrating pharmacokinetic profiles for these formulations.*

FDA Label Image

10mg Label (Image 04)

Label for Methylphenidate HCl Extended-Release Capsules 10 mg manufactured by Sandoz Inc. The label indicates the product is a human prescription drug, extended-release oral capsules, with a package size of 100 capsules. Storage instructions and manufacturer details are provided, including a note to keep out of reach of children and to dispense with a medication guide.*

FDA Label Image

20mg Label (Image 06)

Methylphenidate HCl Extended-Release Capsules 20 mg label from Sandoz Inc. The label states the product is for prescription use and comes in a package of 100 capsules. It includes storage instructions and manufacturer information from Recro Gainesville LLC and Sandoz Inc.*

FDA Label Image

30mg Label (Image 07)

Methylphenidate HCl Extended-Release Capsules 30 mg by Sandoz Inc. The label shows a carton panel with NDC 0781-2363-01, containing 100 capsules for oral use. It includes storage instructions, dispense information, and warnings to keep out of reach of children, with manufacturer details for Recro Gainesville LLC and Sandoz Inc.*

FDA Label Image

40mg Label (Image 08)

Label for Methylphenidate HCl Extended-Release Capsules 40 mg by Sandoz Inc. The label includes dosage form and strength, quantity of 100 capsules, storage instructions, and warnings such as keeping out of reach of children. It also shows the NDC code and manufacturing details.*

FDA Label Image

Figure-2 (Image 09)

A bar chart titled 'CADS-T Total Subscale - Mean Change From Baseline' comparing mean final score changes between Methylphenidate Hydrochloride Extended-release Capsules (n=63) and placebo (n=71). The Methylphenidate group shows a negative mean change around -10.7, while the placebo group shows a positive mean change around 1.27. Error bars represent standard error of the mean.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.